A multicenter, open-labeled, dose-defining trial to investigate the efficacy, safety, pharmacokinetics, and pharmacodynamics of tolvaptan in pediatric congestive heart failure (CHF) patients with volume overload

Trial Profile

A multicenter, open-labeled, dose-defining trial to investigate the efficacy, safety, pharmacokinetics, and pharmacodynamics of tolvaptan in pediatric congestive heart failure (CHF) patients with volume overload

Recruiting
Phase of Trial: Phase III

Latest Information Update: 28 Aug 2017

At a glance

  • Drugs Tolvaptan (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 21 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top